Please login to the form below

gemcitabine

This page shows the latest gemcitabine news and features for those working in and with pharma, biotech and healthcare.

CTI slumps as Servier-partnered lymphoma drug fails

gemcitabine in aggressive B-cell NHL, but found that CTI’s drug was unable to improve progression-free survival (PFS), its primary endpoint.

Latest news

NICE knocks-back Shire's pancreatic cancer drug Onivyde

The watchdog was reviewing the treatment’s use in England and Wales for metastatic pancreatic cancer that has progressed after gemcitabine-based therapy.
Ipsen buys cancer business from stripped down Merrimack

For the tens of thousands of patients living with pancreatic cancer in the US who have received prior treatment with gemcitabine, Onivyde represents an important, differentiated innovation, given its proven overall
Shire wins EU licence for pancreatic cancer drug Onivyde

following treatment with Lilly's Gemzar (gemcitabine).
HIV prevention pill heads July CHMP recommendations

in adults whose disease has progressed after gemcitabine-based therapy.
Wales backs NHS use of Abraxane despite NICE rejection

gemcitabine for previously-untreated metastatic pancreatic cancer.

More from news
Approximately 1 fully matching, plus 57 partially matching documents found.

Latest Intelligence

The rise of chronic disease in BRIC markets

For late-stage patients, Brazil physicians are more likely to use an anthracycline-based regimen without a taxane in the first line, gemcitabine, paclitaxel or a combination of both in the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Bile Duct Cancer Market Sales, Price, Revenue, Gross Margin and Share 2023

The report elucidates elaborate details about the. 5-fluorouracil. Gemcitabine. Cisplatin. Other.
Marketing strategy in complex environments

cells. A good example of this is the combined use of Abraxane and gemcitabine in the treatment of metastatic adenocarcinoma of the pancreas – Abraxane helps to inhibit cancer cell growth, and ... gemcitabine encourages apoptosis of cell DNA.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Account Manager- Healthcare Advertising: Negotiable

Systematic Reviewer - Oxford: Negotiable

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Principal Health Economist - North-West: Negotiable

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Account Manager / Account Director: Competative

Healthcare Communications Account Directors x 2: Salary TBC

Medical (Scientific) Director: £120, 000 benefits

Account Manager- Healthcare Advertising: Negotiable

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Account Director: Competitive Salary Offered

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Business Development Director – Health Education: excellent commission

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Senior Account Manager: Competitive Salary Offered

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Associate Director: £75, 000-90, 000

Senior Editorial Assistant – Greater Manchester: DOE

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Business Director: Competitive Salary Offered

Account Executive/ Senior Account Executive: competitive Salary Offfered

Subscribe to our email news alerts

PMHub

Add my company

Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?: What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma: Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies: Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...